PL360652A1 - Zastosowanie kompozycji zawierającej ekstrakt z pyłku do leczenie zaburzeń hormonalnych - Google Patents

Zastosowanie kompozycji zawierającej ekstrakt z pyłku do leczenie zaburzeń hormonalnych

Info

Publication number: PL360652A1
Authority: PL; Poland
Prior art keywords: pollen; treatment; composition; extract; hormonally
Prior art date: 2000-09-01

Application number

PL36065201A

Other languages

English (en)

Other versions

PL202468B1 (pl

Inventor

Kaj Winter

Christer Hedman

Lars Kärnerud

Original Assignee

Natumin Pharma Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-01

Filing date

2001-08-31

Publication date

2004-09-20

2001-08-31 Application filed by Natumin Pharma Ab filed Critical Natumin Pharma Ab

2004-09-20 Publication of PL360652A1 publication Critical patent/PL360652A1/pl

2009-06-30 Publication of PL202468B1 publication Critical patent/PL202468B1/pl

Links

239000000203 mixture Substances 0.000 title abstract 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
229930003427 Vitamin E Natural products 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000001086 cytosolic effect Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229940109850 royal jelly Drugs 0.000 abstract 1
229940046009 vitamin E Drugs 0.000 abstract 1
235000019165 vitamin E Nutrition 0.000 abstract 1
239000011709 vitamin E Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Insects & Arthropods (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Medical Informatics (AREA)
Animal Husbandry (AREA)
Obesity (AREA)
Zoology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)

PL360652A 2000-09-01 2001-08-31 Zastosowanie kompozycji zawierającej ekstrakt z pyłku i ewentualnie słupków do wytwarzania leku PL202468B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0003092A SE0003092D0 (sv)	2000-09-01	2000-09-01	New Use
PCT/SE2001/001851 WO2002017944A1 (en)	2000-09-01	2001-08-31	Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders

Publications (2)

Publication Number	Publication Date
PL360652A1 true PL360652A1 (pl)	2004-09-20
PL202468B1 PL202468B1 (pl)	2009-06-30

Family

ID=20280860

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL360652A PL202468B1 (pl)	2000-09-01	2001-08-31	Zastosowanie kompozycji zawierającej ekstrakt z pyłku i ewentualnie słupków do wytwarzania leku

Country Status (10)

Country	Link
EP (5)	EP1313492B1 (pl)
JP (5)	JP2004507508A (pl)
AT (5)	ATE283061T1 (pl)
AU (7)	AU2001282814B2 (pl)
CA (5)	CA2424146A1 (pl)
DE (5)	DE60107441D1 (pl)
NO (1)	NO330691B1 (pl)
PL (1)	PL202468B1 (pl)
SE (1)	SE0003092D0 (pl)
WO (5)	WO2002017942A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005139150A (ja) *	2003-11-10	2005-06-02	Api Co Ltd	エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
US7887851B2 (en) *	2004-06-07	2011-02-15	Kao Corporation	Aromatase activator
CN104027100A (zh) *	2014-06-12	2014-09-10	山东中弘信息科技有限公司	一种基于最近历史值的血压异常数据处理方法
KR101533197B1 (ko) *	2014-09-18	2015-07-02	성균관대학교산학협력단	부테인을 포함하는 부종의 예방 또는 치료용 조성물
FR3055215B1 (fr) *	2016-08-31	2020-02-14	S.A.M. Serelys Pharma	Composition comprenant des extraits de pollen et /ou de pistils
CN106138856A (zh) *	2016-09-30	2016-11-23	四川易创生物科技有限公司	一种治疗经间期出血的新型中药组合物及制备方法
EP3335717A1 (en) *	2016-12-13	2018-06-20	Serelys Pharma S.A.M.	Composition for use in treating symptoms relating to premenstrual syndrome (pms)
FR3070263B1 (fr) *	2017-08-28	2020-07-24	Serelys Pharma S A M	Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2970957B2 (ja) *	1991-05-15	1999-11-02	株式会社グレイトチレン	精製花粉栄養調整物
ES2081255B1 (es) *	1994-01-05	1996-09-01	Ind Farma Especial	Aplicacion de las proteinas receptoras de autoincompatibilidad (slsg) de plantas para el tratamiento de las enfermedades alergicas.
US5569459A (en) *	1995-02-15	1996-10-29	Bio-Virus Research Incorporated	Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH09278665A (ja) *	1996-04-10	1997-10-28	Api Kk	花粉エキスソフトカプセル剤及びその製造方法
KR100669875B1 (ko) *	1998-02-23	2007-01-16	다이요 가가꾸 가부시끼가이샤	테아닌 함유 조성물

2000
- 2000-09-01 SE SE0003092A patent/SE0003092D0/xx unknown
2001
- 2001-08-31 CA CA002424146A patent/CA2424146A1/en not_active Abandoned
- 2001-08-31 AU AU2001282814A patent/AU2001282814B2/en not_active Expired
- 2001-08-31 EP EP01961554A patent/EP1313492B1/en not_active Expired - Lifetime
- 2001-08-31 WO PCT/SE2001/001849 patent/WO2002017942A1/en not_active Ceased
- 2001-08-31 CA CA002424011A patent/CA2424011A1/en not_active Abandoned
- 2001-08-31 WO PCT/SE2001/001848 patent/WO2002017941A1/en not_active Ceased
- 2001-08-31 CA CA2420823A patent/CA2420823C/en not_active Expired - Lifetime
- 2001-08-31 AT AT01963652T patent/ATE283061T1/de not_active IP Right Cessation
- 2001-08-31 AU AU2001282816A patent/AU2001282816A1/en not_active Abandoned
- 2001-08-31 AU AU8458101A patent/AU8458101A/xx active Pending
- 2001-08-31 DE DE60107441T patent/DE60107441D1/de not_active Expired - Lifetime
- 2001-08-31 WO PCT/SE2001/001851 patent/WO2002017944A1/en not_active Ceased
- 2001-08-31 DE DE60107442T patent/DE60107442D1/de not_active Expired - Lifetime
- 2001-08-31 JP JP2002522915A patent/JP2004507508A/ja active Pending
- 2001-08-31 CA CA002424026A patent/CA2424026A1/en not_active Abandoned
- 2001-08-31 AU AU2001282813A patent/AU2001282813A1/en not_active Abandoned
- 2001-08-31 DE DE60107443T patent/DE60107443D1/de not_active Expired - Lifetime
- 2001-08-31 WO PCT/SE2001/001850 patent/WO2002017943A1/en not_active Ceased
- 2001-08-31 EP EP01963652A patent/EP1313496B1/en not_active Expired - Lifetime
- 2001-08-31 AU AU2001284581A patent/AU2001284581B2/en not_active Ceased
- 2001-08-31 EP EP01961555A patent/EP1313493B1/en not_active Expired - Lifetime
- 2001-08-31 CA CA2420906A patent/CA2420906C/en not_active Expired - Lifetime
- 2001-08-31 AT AT01961557T patent/ATE283060T1/de not_active IP Right Cessation
- 2001-08-31 AT AT01961556T patent/ATE286739T1/de not_active IP Right Cessation
- 2001-08-31 JP JP2002522916A patent/JP2004507509A/ja active Pending
- 2001-08-31 WO PCT/SE2001/001847 patent/WO2002017940A1/en not_active Ceased
- 2001-08-31 AT AT01961554T patent/ATE283058T1/de not_active IP Right Cessation
- 2001-08-31 JP JP2002522917A patent/JP4896354B2/ja not_active Expired - Lifetime
- 2001-08-31 DE DE60108402T patent/DE60108402D1/de not_active Expired - Lifetime
- 2001-08-31 JP JP2002522914A patent/JP2004507507A/ja active Pending
- 2001-08-31 JP JP2002522913A patent/JP2004507506A/ja active Pending
- 2001-08-31 AT AT01961555T patent/ATE283059T1/de not_active IP Right Cessation
- 2001-08-31 EP EP01961556A patent/EP1313494B1/en not_active Expired - Lifetime
- 2001-08-31 DE DE60107444T patent/DE60107444T2/de not_active Expired - Lifetime
- 2001-08-31 AU AU2001282815A patent/AU2001282815A1/en not_active Abandoned
- 2001-08-31 EP EP01961557A patent/EP1313495B1/en not_active Expired - Lifetime
- 2001-08-31 PL PL360652A patent/PL202468B1/pl unknown
- 2001-08-31 AU AU8281401A patent/AU8281401A/xx active Pending
2003
- 2003-03-03 NO NO20030988A patent/NO330691B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2002017942A1 (en)	2002-03-07
WO2002017941A1 (en)	2002-03-07
NO330691B1 (no)	2011-06-14
SE0003092D0 (sv)	2000-09-01
AU2001284581B2 (en)	2006-09-21
AU2001282814B2 (en)	2006-12-21
DE60107441D1 (de)	2004-12-30
EP1313494B1 (en)	2005-01-12
EP1313493A1 (en)	2003-05-28
EP1313492B1 (en)	2004-11-24
JP2004507507A (ja)	2004-03-11
NO20030988D0 (no)	2003-03-03
PL202468B1 (pl)	2009-06-30
EP1313496A1 (en)	2003-05-28
DE60107444T2 (de)	2005-12-08
EP1313495B1 (en)	2004-11-24
AU8281401A (en)	2002-03-13
ATE286739T1 (de)	2005-01-15
CA2420906A1 (en)	2002-03-07
EP1313492A1 (en)	2003-05-28
JP2004507510A (ja)	2004-03-11
CA2424146A1 (en)	2002-03-07
ATE283059T1 (de)	2004-12-15
AU2001282813A1 (en)	2002-03-13
ATE283058T1 (de)	2004-12-15
DE60107442D1 (de)	2004-12-30
WO2002017940A1 (en)	2002-03-07
CA2420906C (en)	2014-07-15
ATE283061T1 (de)	2004-12-15
EP1313495A1 (en)	2003-05-28
JP4896354B2 (ja)	2012-03-14
WO2002017944A1 (en)	2002-03-07
ATE283060T1 (de)	2004-12-15
WO2002017943A1 (en)	2002-03-07
CA2424011A1 (en)	2002-03-07
EP1313496B1 (en)	2004-11-24
CA2420823A1 (en)	2002-03-07
AU8458101A (en)	2002-03-13
AU2001282815A1 (en)	2002-03-13
CA2424026A1 (en)	2002-03-07
CA2420823C (en)	2014-07-15
JP2004507509A (ja)	2004-03-11
JP2004507506A (ja)	2004-03-11
AU2001282816A1 (en)	2002-03-13
DE60107443D1 (de)	2004-12-30
DE60108402D1 (de)	2005-02-17
DE60107444D1 (de)	2004-12-30
EP1313493B1 (en)	2004-11-24
JP2004507508A (ja)	2004-03-11
EP1313494A1 (en)	2003-05-28
NO20030988L (no)	2003-03-03

Publication	Publication Date	Title
IL154888A (en)	2013-12-31	Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
WO1997048391A3 (en)	1998-01-29	Methods and compositions comprising r-ibuprofen
FI956014A0 (fi)	1995-12-14	Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
IL150706A0 (en)	2003-02-12	Composition and methods for the treatment of skin disorders
EP1025850A4 (en)	2002-08-14	COMPOSITIONS CONTAINING ISOFLAVONE
DK1071439T3 (da)	2006-10-16	Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis
TR200103710T2 (tr)	2002-06-21	Vajinal mukozayı etkileyen patolojilerin topikal tedavisinde kullanıma yönelik E vitamini
IT1263840B (it)	1996-09-04	Formulazioni orali di ubidecarenone in forma di capsule
PL360652A1 (pl)	2004-09-20	Zastosowanie kompozycji zawierającej ekstrakt z pyłku do leczenie zaburzeń hormonalnych
WO2002024216A3 (en)	2004-07-15	Method for use of igf-binding protein for selective sensitization of target cells in vivo
BR0314787A (pt)	2005-07-26	Forma de dosagem de liberação modificada
AU2003290015A1 (en)	2004-07-09	Mastitis treatment
IL148777A (en)	2013-10-31	Mirtazepine oral oral administration unit
WO2006032115A3 (en)	2006-08-03	Composition against cardiovascular diseases
CN102989033A (zh)	2013-03-27	卫生巾及护垫生产中的添加剂及其制备方法
WO2001043705A3 (en)	2001-12-13	Compositions containing a retinoid and a stilbene for skin care
EE200100689A (et)	2003-02-17	IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
EP1074254A3 (en)	2002-09-11	Use of plant polyphenols with vitamines for treating iron overload
ES2185310T3 (es)	2003-04-16	Agente antivirico herbario.
NZ504351A (en)	2002-10-25	Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
WO2002087604A3 (de)	2002-12-19	Präparationen von vitamin e in kombination mit afamin
MD1473F2 (en)	2000-05-31	Antiherpetic remedy
WO2002051404A8 (fr)	2003-11-13	Compositions orales
ZA200207846B (en)	2004-02-11	Topical antioxidant vitamin composition for skin care.
JPS568324A (en)	1981-01-28	Infectious disease remedy for external and ophthalmologic application